Intensity-modulated radiotherapy for gliomas: dosimetric effects of changes in gross tumor volume on organs at risk and healthy brain tissue
Open Access
- 1 June 2016
- journal article
- research article
- Published by Informa UK Limited in OncoTargets and Therapy
- Vol. 9, 3545-3554
- https://doi.org/10.2147/OTT.S100455
Abstract
Aim: The aim of this study was to explore the effects of changes in the gross tumor volume (GTV) on dose distribution in organs at risk (OARs) and healthy brain tissue in patients with gliomas. Methods: Eleven patients suffering from gliomas with intensity-modulated radiotherapy (IMRT) plans treated with a simultaneous integrated boost technique planned before therapy (initial plans) were prospectively enrolled. At the end of radiotherapy, patients underwent repeat computed tomography and magnetic resonance imaging, and IMRT was replanned. The GTV and dosimetric parameters between the initial and replanned IMRT were compared using the Wilcoxon two-related-sample test, and correlations between the initial GTV and the replanned target volumes were assessed using the bivariate correlation test. Results: The volume of the residual tumor did not change significantly (P>0.05), the volume of the surgical cavity decreased significantly (PPPP Conclusion: The reduction in the GTV in patients with gliomas resulted from shrinkage of the surgical cavity during IMRT, leading to decreased doses to the OARs and healthy brain tissue. Such changes appeared to be most meaningful in patients with large initial GTV values.This publication has 18 references indexed in Scilit:
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010Neuro-Oncology, 2013
- RTOG 0913: A Phase 1 Study of Daily Everolimus (RAD001) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GlioblastomaInternational Journal of Radiation Oncology*Biology*Physics, 2013
- Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomasRadiation Oncology, 2012
- The Role of Adjuvant Radiation Therapy in the Management of High-Grade GliomasNeurosurgery Clinics of North America, 2012
- Concurrent Temozolomide and Dose-Escalated Intensity-Modulated Radiation Therapy in Newly Diagnosed GlioblastomaClinical Cancer Research, 2012
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Intensity modulated radiation therapy versus three‐dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparisonJournal of Applied Clinical Medical Physics, 2007
- Evaluating changes in tumor volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: Implications for conformal dose-escalation studiesInternational Journal of Radiation Oncology*Biology*Physics, 2005
- T2 weighted MRI in assessment of volume changes during radiotherapy of high grade gliomasJournal of Cancer Research and Therapeutics, 2005
- Radiotherapy for newly diagnosed malignant glioma in adults: a systematic reviewRadiotherapy and Oncology, 2002